Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary
In a bid to bring joy and smiles to people’s faces, Apsara Ice Creams today announced the launch of a unique initiative titled Muskaan on its 53rd Anniversary on the occasion of the 78th Independence Day. Apsara Ice Creams is…
New SPECT Study Unveils Significant Brain Activity Differences in Depression
Researchers in a groundbreaking neuroimaging study have discovered that individuals with depression exhibit significantly higher levels of blood flow in various brain regions. Key findings from the study indicate that depressed patients show increased blood flow in critical brain areas,…
COAST GUARD VETERAN WALKING ACROSS AMERICA TO RAISE AWARENESS FOR MENTAL HEALTH
The Coast Guard Foundation, a non-profit organization committed to strengthening the Coast Guard community and service by supporting members and families, announced that Robert Luna, a retired Coast Guard veteran and chief petty officer, is walking from Alabama to California to raise awareness for mental…
Helping Combat Drug Abuse in Valencia
Volunteers gathered at the Church of Scientology Mission of Valencia to launch a drug education initiative to tackle an urgent issue affecting their city. They reached out with drug prevention booklets to inform people of the unvarnished facts about the most commonly…
Acharya Prashant Engages with IIT Students on Mental Health and Spiritual Well-being
Acharya Prashant, founder of PrashantAdvait Foundation and former civil service officer, interacted with IIT students on mental health. More than 1000 people from across the country participated in the session. He said that there is a deep connection between the…
Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis
New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European Psychiatric Association held April 6-9 in Budapest, Hungary. According to scientific posters of the event, cariprazine could be an appropriate treatment not only for…
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
The9 Limited (Nasdaq: NCTY) (“The9”), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) (“WM Therapeutics”) has achieved revolutionary breakthroughs in the proprietarily developed research and development of antidepressant drug precision treatment. WM Therapeutics’ GenAI multi-dimensional omics…
Mansathali Intervenes to Rescue Child from Social Media Addiction
Today, the whole world is dominated by digital technology; it doesn’t matter what your age or gender is, you are tech addicted. Concerns about the impact of social media addiction on children’s well-being have become more pressing than ever. However,…
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder. NBI-1070770 is a novel,…
Join Els for Autism® in Celebrating World Autism Month: Creating Opportunities for Inclusion and Acceptance of Individuals with Autism Spectrum Disorder
As we prepare to celebrate World Autism Month this April, Els for Autism invites individuals and families to join us in our mission of creating a world of limitless possibilities for individuals with autism spectrum disorder (ASD) and their families. Through our…
